This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

Merlin Biotech, Inc.

Profile

Company/Organization Description or Summary

MERLIN Biotech is an mRNA platform start-up innovative biotechnology spinout from the Baruch S. Blumberg Institute. It is leveraging proven mRNA technology to develop novel therapeutics and vaccines against targets, which address important unmet medical needs that include chronic hepatitis B, adult and pediatric cancers, and Lyme disease.   MERLIN Biotech’s executive management and boards include a former Moderna Senior VP, a  Nobel Prize winner and global experts in mRNA development, oncology immune-modulators, chronic hepatitis B, and preventive vaccines for Lyme disease.

We're bringing you

  • Startup Springboard

    3:00pm